Sigma Planning Corp raised its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 39.9% in the 4th quarter, HoldingsChannel reports. The fund owned 17,111 shares of the pharmacy operator’s stock after buying an additional 4,877 shares during the quarter. Sigma Planning Corp’s holdings in Walgreens Boots Alliance were worth $1,243,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after purchasing an additional 1,926,108 shares during the period. Franklin Resources Inc. boosted its position in shares of Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after purchasing an additional 3,662,302 shares during the period. Nordea Investment Management AB boosted its position in shares of Walgreens Boots Alliance by 1.0% in the 3rd quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock valued at $786,284,000 after purchasing an additional 96,552 shares during the period. CI Global Investments Inc. boosted its position in shares of Walgreens Boots Alliance by 32.0% in the 4th quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock valued at $535,470,000 after purchasing an additional 1,785,449 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in shares of Walgreens Boots Alliance by 12.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,641,826 shares of the pharmacy operator’s stock valued at $512,893,000 after purchasing an additional 735,917 shares during the period. 61.57% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently issued reports on WBA. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 24th. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 3rd. Finally, Evercore ISI began coverage on Walgreens Boots Alliance in a research report on Thursday, January 4th. They issued an “outperform” rating and a $80.00 target price for the company. Ten investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $85.05.

In other Walgreens Boots Alliance news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The stock was acquired at an average cost of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 14.80% of the company’s stock.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $68.49 on Thursday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The company has a market capitalization of $67,850.00, a P/E ratio of 18.92, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.10 EPS. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 44.20%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s management believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “Sigma Planning Corp Has $1.24 Million Stake in Walgreens Boots Alliance Inc (WBA)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/15/sigma-planning-corp-has-1-24-million-stake-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.